Jfs Wealth Advisors, LLC Seagen Inc. Transaction History

Jfs Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$127.59 - $203.08 $382 - $609	-3 Reduced 7.32%	38 $7,000
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $117 - $139	-1 Reduced 2.38%	41 $5,000
Q3 2022 Oct 21, 2022	BUY	$135.27 - $180.11 $811 - $1,080	6 Added 16.67%	42 $6,000
Q2 2022 Aug 02, 2022	BUY	$108.81 - $179.33 $1,958 - $3,227	18 Added 100.0%	36 $6,000
Q1 2022 May 02, 2022	SELL	$119.61 - $157.85 $6,458 - $8,523	-54 Reduced 75.0%	18 $3,000
Q4 2021 Feb 03, 2022	SELL	$142.57 - $190.86 $77,272 - $103,446	-542 Reduced 88.27%	72 $11,000
Q3 2021 Nov 09, 2021	BUY	$142.45 - $169.82 $87,464 - $104,269	614 New	614 $104,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.